Gastric Cancer
📧 Sign up to get email alerts when something new happens for Gastric Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: Safety and Efficacy of Glumetinib Combined With Docetaxel for Injection (Albumin-bound) in Patients With Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma and Other Solid Tumors [Phase 2]
Phase 2 clinical trial evaluating Glumetinib in combination with Nab-docetaxel for advanced gastric/gastroesophageal junction cancers and ot…
-
CLINICAL_TRIALS trial_result · 2025-09-08Clinical Trial Update: Comparing the Efficacy and Safety of Different Postoperative Adjuvant Regimens in Patients With Resectable Adenocarcinoma of the Esophagogastric Junction Who Underwent Radical Surgery After Neoadjuvant Chemotherapy Combined With Immunotherapy and Achieved pCR in Postoperative Pathology [Phase 4]
Phase 4 trial evaluating different postoperative adjuvant regimens after radical surgery for resectable gastric or gastroesophageal junction…
-
CLINICAL_TRIALS research · 2025-09-05Clinical Trial Update: Effectiveness of ERAS on Postoperative Recovery After Minimally Invasive Gastrectomy [NA]
A clinical trial is evaluating whether enhanced recovery after surgery (ERAS) improves postoperative recovery after minimally invasive gastr…
-
CLINICAL_TRIALS research · 2025-09-04Clinical Trial Update: Omentum Preservation Versus Complete Omentectomy in Gastrectomy for Gastric Cancer [NA]
A clinical trial sponsored by Amsterdam UMC compares omentum preservation versus complete omentectomy during gastrectomy for gastric cancer …
-
CLINICAL_TRIALS research · 2025-09-03Clinical Trial Update: Immunotherapy Combined With Anti-angiogenic Therapy and Chemotherapy for Potentially Resectable MSI-H, dMMR Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma [Phase 2]
A Phase 2 clinical trial is evaluating a combination of immunotherapy, anti-angiogenic therapy, and chemotherapy in MSI-H/dMMR locally advan…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-09-03Clinical Trial Update: SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors [Phase 1]
Phase 1 trial of SON-DP in participants with relapsed/refractory solid tumors intolerant to standard therapies, including gastric cancer and…
-
CLINICAL_TRIALS research · 2025-09-02Clinical Trial Update: Exploration of Lymph Node Metastasis and Tumor Deposit in the Posterior Gastric Mesentery for Distal Gastric Cancer
A clinical trial is recruiting to study lymph node metastasis and tumor deposits in the posterior gastric mesentery for distal gastric cance…
-
CLINICAL_TRIALS research · 2025-09-02Clinical Trial Update: Analysis of Lymph Node Metastasis and Tumor Deposit in the Short Gastric Mesentery Following Total Gastrectomy for Gastric Cancer
A clinical trial update (NCT06728878) examining lymph node metastasis and tumor deposits in the short gastric mesentery after total gastrect…
-
CLINICAL_TRIALS research · 2025-09-02Clinical Trial Update: Analysis of Tumor Deposit at the Fusion Site of the Right Gastric Mesentery and Left Gastric Mesentery in the Patients With Gastric Cancer Who Received Proximal Gastrectomy
This clinical trial update describes a study evaluating tumor deposits at the fusion site of the right gastric mesentery and left gastric me…
-
CLINICAL_TRIALS research · 2025-08-29Clinical Trial Update: Sentinel Lymph Node Detection in Gastric Cancer Using a Dual Tracer (Superparamagnetic Iron Oxide and Methylene Blue): A Prospective Study With Histological and OSNA Validation
A prospective study evaluating sentinel lymph node detection in gastric cancer using dual tracers (superparamagnetic iron oxide and methylen…
-
CLINICAL_TRIALS trial_result · 2025-08-29Clinical Trial Update: Comparing the Efficacy and Safety of Chemotherapy Combined With or Without Immunotherapy as Postoperative Adjuvant Regimens in Patients With Resectable Gastric Cancer/Adenocarcinoma of the Esophagogastric Junction After Radical Surgery [Phase 4]
A Phase 4 trial update describing a study that compares postoperative adjuvant regimens of chemotherapy with or without immunotherapy in pat…
-
CLINICAL_TRIALS trial_result · 2025-08-28Clinical Trial Update: A Study to Evaluate AB308 in Combination With AB122 in Participants With Advanced Malignancies [Phase 1]
The Phase 1 study evaluating AB308 in combination with AB122 in participants with advanced malignancies has been completed.
-
CLINICAL_TRIALS research · 2025-08-28Clinical Trial Update: MAIC of Fruquintinib Plus Paclitaxel Versus Ramucirumab Plus Paclitaxel in Advanced G/GEJ Adenocarcinoma
Clinical trial update describing a matching-adjusted indirect comparison (MAIC) of Fruquintinib plus paclitaxel versus ramucirumab plus pacl…
-
CLINICAL_TRIALS trial_result · 2025-08-27Clinical Trial Update: taVNS Reduces Postoperative Pain and Complications in Patients With Gastric and Intestinal Tumors [NA]
A completed clinical trial suggests that transcutaneous auricular vagus nerve stimulation (taVNS) reduces postoperative pain and complicatio…
-
CLINICAL_TRIALS research · 2025-08-27Clinical Trial Update: Cytoreductive Gastrectomy After Systemic Therapy Versus Systemic Therapy Alone For Limited Metastasis Gastric Cancer [NA]
This clinical trial evaluates cytoreductive gastrectomy after systemic therapy versus systemic therapy alone for limited metastatic gastric …
-
CLINICAL_TRIALS research · 2025-08-27Clinical Trial Update: [18F]F-FAPI PET/CT and Laparoscopy in Staging Advanced Gastric Cancer [Phase 2, Phase 3]
This Phase 2/Phase 3 trial from Leiden University Medical Center is evaluating [18F]F-FAPI PET/CT with laparoscopy for staging locally advan…
-
CLINICAL_TRIALS research · 2025-08-26Clinical Trial Update: Safety Comparison of Total Laparoscopic Proximal Gastrectomy With or Without Preservation of the Celiac Branch of the Vagus Nerve for Early Upper Gastric Cancer: A Randomized Controlled Clinical Trial [NA]
An ongoing randomized controlled trial compares safety outcomes of total laparoscopic proximal gastrectomy with and without preserving the c…
-
CLINICAL_TRIALS trial_result · 2025-08-24Clinical Trial Update: A Study of [225Ac]-FPI-2059 in Adult Participants With Solid Tumours [Phase 1]
A Phase 1 study of [225Ac]-FPI-2059 in adults with solid tumours was terminated.
-
CLINICAL_TRIALS research · 2025-08-24Clinical Trial Update: HER-2 B Cell Peptide Vaccine [Phase 1]
Phase 1 clinical trial update for a HER-2 B cell peptide vaccine in metastatic breast and gastric cancers; recruitment ongoing.
-
CLINICAL_TRIALS research · 2025-08-24Clinical Trial Update: A Multicenter, Phase 3 Study of IBI343 Monotherapy Versus Treatment of Investigator's Choice in Subjects With Previously Treated, Claudin (CLDN) 18.2-positive, HER2-negative, Gastric or Gastroesophageal Junction Adenocarcinoma [Phase 3]
Phase 3 multicenter trial evaluating IBI343 monotherapy versus investigator's choice in previously treated CLDN18.2-positive, HER2-negative …
-
CLINICAL_TRIALS research · 2025-08-22Clinical Trial Update: ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Guardant Health's ORACLE trial is currently recruiting to evaluate residual cancer using a liquid biopsy across multiple cancer types.
-
FDA approval · 2025-08-21FDA Approved: TRAZIMERA — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for TRAZIMERA (trastuzumab-qyyp) from Pfizer Laboratories Div Pfizer Inc, authorizing changes under …
-
CLINICAL_TRIALS research · 2025-08-21Clinical Trial Update: INTERACT Stomach-II [Phase 2]
This is a Phase II clinical trial update for INTERACT Stomach-II in gastric cancer with peritoneal metastases, with the study currently not …
-
CLINICAL_TRIALS trial_result · 2025-08-21Clinical Trial Update: A Study of Treatment Patterns in HER2-positive Unresectable and Advanced Gastric/ Gastroesophageal Junction Cancer in China
Completed clinical trial in China evaluating treatment patterns for patients with HER2-positive unresectable or advanced gastric cancer and …
-
CLINICAL_TRIALS research · 2025-08-21Clinical Trial Update: Zimberelimab Anti-PD1 +/- Domvanalimab in Resectable Mmrd Gastric Cancer [Phase 2]
Phase 2 trial update examining zimberelimab with or without domvanalimab in resectable MSI-H/dMMR gastric and gastroesophageal junction canc…